YSB Inc. (HKG:9885)
Hong Kong · Delayed Price · Currency is HKD 5.79
+0.12 (2.12%)
Jan 28, 2026, 4:08 PM HKT
YSB Inc. Revenue
YSB Inc. had revenue of 9.84B CNY in the half year ending June 30, 2025, with 23.52% growth. This brings the company's revenue in the last twelve months to 18.93B, up 6.26% year-over-year. In the year 2024, YSB Inc. had annual revenue of 17.90B with 5.49% growth.
Revenue (ttm)
18.93B CNY
Revenue Growth
+6.26%
P/S Ratio
0.19
Revenue / Employee
2.86M CNY
Employees
6,620
Market Cap
3.93B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.90B | 931.33M | 5.49% |
| Dec 31, 2023 | 16.97B | 2.70B | 18.90% |
| Dec 31, 2022 | 14.27B | 4.18B | 41.43% |
| Dec 31, 2021 | 10.09B | 4.03B | 66.43% |
| Dec 31, 2020 | 6.06B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| Alibaba Health Information Technology | 36.09B |
| Fangzhou | 3.15B |
| Shanghai Pioneer Holding | 1.49B |
| Kingworld Medicines Group | 1.03B |
| Tycoon Group Holdings | 951.11M |
| Universal Health International Group Holding | 779.66M |
| New Ray Medicine International Holding | 121.93M |